A brief history of the antibiotic era: Lessons learned and challenges for the future

Frontiers in Microbiology

Volumn 1, Issue DEC, 2010, Pages

  Aminov, Rustam I ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Antibiotic resistance; Environmental resistome; History of antibiotic discovery; Novel antimicrobials; Prevention of antibiotic resistance

Indexed keywords

EID: 79960399031     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2010.00134     Document Type: Article

References (77)

1. Abraham, E. P., and Chain, E. (1940). An enzyme from bacteria able to destroy penicillin. Nature 146, 837.
2. Aminov, R. I. (2009). The role of antibiotics and antibiotic resistance in nature. Environ. Microbiol. 11, 2970-2988.
3. Aminov, R. I., and Mackie, R. I. (2007). Evolution and ecology of antibiotic resistance genes. FEMS Microbiol. Lett. 271, 147-161.
4. Armelagos, G. J. (1969). Disease in ancient Nubia. Science 163, 225-258.
5. Bassett, E. J., Keith, M. S., Armelagos, G. J., Martin, D. L., and Villanueva, A. R. (1980). Tetracycline-labeled human bone from ancient Sudanese Nubia (A.D. 350). Science 209, 1532-1534.
6. Beaber, J. W., Hochhut, B., and Waldor M. K. (2004). SOS response promotes horizontal dissemination of antibiotic resistance genes. Nature 427, 72-74.
7. Bengtsson, B., and Wierup, M. (2006). Ant imicrobial resistance in Scandinavia after ban of antimicrobial growth promoters. Anim. Biotechnol. 17, 147-156.
8. Bush, K., and Macielag, M. J. (2010). New β-lactam antibiotics and β-lactamase inhibitors. Expert Opin. Ther. Pat. 20, 1277-1293.
9. Cha, J. Y., Ishiwata, A., and Mobashery, S. (2004). A novel β-lactamase activity from a penicillin-binding protein of Treponema pallidum and why syphilis is still treatable with penicillin. J. Biol. Chem. 279, 14917-14921.
10. Chain, E., Florey, H. W., Gardner, A. D., Heatley, N. G., Jennings, M. A., Orr-Ewing, J., and Sanders, A. G. (2005). The classic: penicillin as a chemotherapeutic agent. 1940. Clin. Orthop. Relat. Res. 439, 23-26.
11. Chee-Sanford, J. C., Mackie, R. I., Koike, S., Krapac, I. G., Lin, Y. F., Yannarell, A. C., Maxwell, S., and Aminov, R. I. (2009). Fate and transport of antibiotic residues and antibiotic resistance genes following land application of manure waste. J. Environ. Qual. 38, 1086-1108.
12. Chopra, I., Hesse, L., and O'Neill, A. (2002). "Discovery and development of new anti-bacterial drugs," in Pharmacochemistry Library, Vol. 32, Trends in Drug Research III, ed. H. van der Goot (Amsterdam: Elsevier), 213-225.
13. Clatworthy, A. E., Pierson, E., and Hung, D. T. (2007). Targeting virulence: a new paradigm for antimicrobial therapy. Nat. Chem. Biol. 3, 541-548.
14. Cook, M., Molto, E., and Anderson, C. (1989). Fluorochrome labelling in Roman period skeletons from Dakhleh Oasis, Egypt. Am. J. Phys. Anthropol. 80, 137-143.
15. Cui, L., and Su, X. Z. (2009). Discovery, mechanisms of action andcombination therapy of artemisinin. Expert Rev. Anti. Infect. Ther. 7, 999-1013.
16. Davies, J., Spiegelman, G. B., and Yim, G. (2006). The world of subinhibitory antibiotic concentrations. Curr. Opin. Microbiol. 9, 445-453.
17. de la Cueva-Méndez, G., and Pimentel, B. (2007). Gene and cell survival: lessons from prokaryotic plasmid R1. EMBO Rep. 8, 458-464.
18. Devasahayam, G., Scheld, W. M., and Hoffman, P. S. (2010). Newer antibacterial drugs for a new century. Expert Opin. Investig. Drugs 19, 215-234.
19. Diacon, A. H., Pym, A., and Grobusch, M. (2009). The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N. Engl. J. Med. 360, 2397-2405.
20. Domagk, G. (1935). Ein Beitrag zur Chemotherapie der bakteriellen Infektionen. Dtsch. Med. Wochenschr. 61, 250.
21. Dubern, J. F., and Diggle, S. P. (2008). Quorum sensing by 2-alkyl-4-quinolones in Pseudomonas aeruginosa and other bacterial species. Mol Biosyst 4, 882-888.
22. Ehrlich, P., and Hata, S. (1910). Die Experimentelle Chemotherapie der Spirilosen. Berlin: Julius Springer.
23. Emmerich, R., and Löw, O. (1899). Bakteriolytische enzyme als Ursache der erworbenen Immunität und die Heilung von Infectionskrankheiten durch dieselben. Z. Hyg. 31, 1-65.
24. Enne, V. I., Bennett, P. M., Livermore, D. M., and Hall, L. M. (2004). Enhancement of host fitness by the sul2-coding plasmid p9123 in the absence of selective pressure. J. Antimicrob. Chemother. 53, 958-963.
25. European Centre for Disease Prevention and Control/European Medicines Agency Joint Working Group (ECDC/EMEA). (2009). The Bacterial Challenge: Time to React. Available at www.ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf.
26. Fajardo, A., and Martínez, J. L. (2008). Antibiotics as signals that trigger specific bacterial responses. Curr. Opin. Microbiol. 11, 161-167.
27. Falkinham, J. O. 3rd, Wall, T. E., Tanner, J. R., Tawaha, K., Alali, F. Q., Li, C., and Oberlies, N. H. (2009). Proliferation of antibiotic-producing bacteria and concomitant antibiotic production as the basis for the antibiotic activity of Jordan's red soils. Appl. Environ. Microbiol. 75, 2735-2741.
28. Fevre, C., Jbel, M., Passet, V., Weill, F. X., Grimont, P. A., and Brisse, S. (2005). Six groups of the OXY β-lactamase evolved over millions of years in Klebsiella oxytoca. Antimicrob. Agents Chemother. 49, 3453-3462.
29. Fleming, A. (1929). On antibacterial action of culture of Penicillium, with special reference to their use in isolation of B. influenzae. Br. J. Exp. Pathol. 10, 226-236.
30. Garau, G., Di Guilmi, A. M., and Hall, B. G. (2005). Structure-based phylogeny of the metallo-beta-lactamases. Antimicrob. Agents Chemother. 49, 2778-2784.
31. Garriss, G., Waldor, M. K., and Burrus, V. (2009). Mobile antibiotic resistance encoding elements promote their own diversity. PLoS Genet. 5, e1000775. doi: 10.1371/journal.pgen.1000775.
32. Gartin, M., Brewis, A. A., and Schwartz, N. A. (2010). Nonprescription antibiotic therapy: cultural models on both sides of the counter and both sides of the border. Med. Anthropol. Q. 24, 85-107.
33. Goossens, H., Ferech, M., Vander Stichele, R., Elseviers, M., and ESAC Project Group. (2005). Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365, 579-587.
34. Gotoh, Y., Eguchi, Y., Watanabe, T., Okamoto, S., Doi, A., and Utsumi, R. (2010). Two-component signal transduction as potential drug targets in pathogenic bacteria. Curr. Opin. Microbiol. 13, 232-239.
35. Griffin, M. O., Fricovsky, E., Ceballos, G., and Villarreal, F. (2010). Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature. Am. J. Physiol. Cell Physiol. 299, C539-C548.
36. Grigoryan, L., Burgerhof, J. G., Degener, J. E., Deschepper, R., Lundborg, C. S., Monnet, D. L., Scicluna, E. A., Birkin, J., Haaijer-Ruskamp, F. M., and SAR Consortium. (2007). Attitudes, beliefs and knowledge concerning antibiotic use and self-medication: a comparative European study. Pharmacoepidemiol. Drug. Saf. 16, 1234-1243.
37. Hall, B. G., and Barlow, M. (2004). Evolution of the serine beta-lactamases: past, present and future. Drug Resist. Updat. 7, 111-123.
38. Hancock, R. E., and Sahl, H. G. (2006). Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24, 1551-1557.
39. Hays, E. E., Wells, I. C., Katzman, P. A., Cain, C. K., Jacobs, F. A., Thayer, S. A., Doisy, E. A., Gaby, W. L., Roberts, E. C., Muir, R. D., Carroll, C. J., Jones, L. R., and Wade, N. J. (1945). Antibiotic substances produced by Pseudomonas aeruginosa. J. Biol. Chem. 159, 725-750.
40. Hegde, S. S., Vetting, M. W., Roderick, S. L., Mitchenall, L. A., Maxwell, A., Takiff, H. E., and Blanchard, J. S. (2005). A fluoroquinolone resistance proteinfrom Mycobacterium tuberculosis that mimics DNA. Science 308, 1480-1483.
41. Hegreness, M., Shoresh, N., Damian, D., Hartl, D., and Kishony, R. (2008). Accelerated evolution of resistance in multidrug environments. Proc. Natl. Acad. Sci. U.S.A. 105, 13977-13981.
42. Hughes, C. C., and Fenical, W. (2010). Antibacterials from the sea. Chemistry 16, 12512-12525.
43. Kaufmann, G. F., Sartorio, R., Lee, S. H., Rogers, C. J., Meijler, M. M., Moss, J. A., Clapham, B., Brogan, A. P., Dickerson, T. J., and Janda, K. D. (2005). Revisiting quorum sensing: discovery of additional chemical and biological functions for 3-oxo-N-acylhomoserine lactones. Proc. Natl. Acad. Sci. U.S.A. 102, 309-314.
44. Keller, M. A., and Stiehm, E. R. (2000). Passive immunity in prevention and treatment of infectious diseases. Clin. Microbiol. Rev. 13, 602-614.
45. Kobayashi, T., Nonaka, L., Maruyama, F., and Suzuki, S. (2007). Molecular evidence for the ancient origin of the ribosomal protection protein that mediates tetracycline resistance in bacteria. J. Mol. Evol. 65, 228-235.
46. Kohanski, M. A., Dwyer, D. J., and Collins, J. J. (2010a). How antibiotics kill bacteria: from targets to networks. Nat. Rev. Microbiol. 8, 423-435.
47. Kohanski, M. A., DePristo, M. A., and Collins, J. J. (2010b). Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol. Cell 37, 311-320.
48. Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., Krishnan, P., Kumar, A. V., Maharjan, S., Mushtaq, S., Noorie, T., Paterson, D. L., Pearson, A., Perry, C., Pike, R., Rao, B., Ray, U., Sarma, J. B., Sharma, M., Sheridan, E., Thirunarayan, M. A., Turton, J., Upadhyay, S., Warner, M., Welfare, W., Livermore, D. M., and Woodford, N. (2010). Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10, 597-602.
49. Lee, H. H., Molla, M. N., Cantor, C. R., and Collins, J. J. (2010). Bacterial charity work leads to population-wide resistance. Nature 467, 82-85.
50. Levin, B. R., and Bull, J. J. (2004). Population and evolutionary dynamics of phage therapy. Nat. Rev. Microbiol. 2, 166-173.
51. Liu, C. I., Liu, G. Y., Song, Y., Yin, F., Hensler, M. E., Jeng, W. Y., Nizet, V., Wang, A. H., and Oldfield, E. (2008). A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science 319, 1391-1394.
52. Lloyd, N. C., Morgan, H. W., Nicholson, B. K., and Ronimus, R. S. (2005). The Composition of Ehrlich's Salvarsan: resolution of a century-old debate. Angew. Chem. Int. Ed. 44, 941-944.
53. Lock, R. L., and Harry, E. J. (2008). Celldivision inhibitors: new insights for future antibiotics. Nat. Rev. Drug Discov. 7, 324-338.
54. Lomovskaya, O., and Bostian, K. A. (2006). Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use. Biochem. Pharmacol. 71, 910-908.
55. Lu, T. K., and Collins, J. J. (2009). Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Proc. Natl. Acad. Sci. U.S.A. 106, 4629-4633.
56. MacNeil, I. A., Tiong, C. L., Minor, C., August, P. R., Grossman, T. H., Loiacono, K. A., Lynch, B. A., Phillips, T., Narula, S., Sundaramoorthi, R., Tyler, A., Aldredge, T., Long, H., Gilman, M., Holt, D., and Osburne, M. S. (2001). Expression and isolation of antimicrobial small molecules from soil DNA libraries. J. Mol. Microbiol. Biotechnol. 3, 301-308.
57. Mahoney, J., Arnold, R., and Harris, A. (1943). Penicillin treatment of early syphilis. A preliminary report. Verer. Dis. Inform. 24, 355-357.
58. Makovitzki, A., Avrahami, D., and Shai, Y. (2006). Ultrashort antibacterial and antifungal lipopeptides. Proc. Natl. Acad. Sci. U.S.A. 103, 15997-16002.
59. Martínez, J. L. (2008). Antibiotics and antibiotic resistance genes in natural environments. Science 321, 365-367.
60. Monk, A. B., Rees, C. D., Barrow, P., Hagens, S., and Harper, D. R. (2010).Bacteriophage applications: where are we now? Lett. Appl. Microbiol. 51, 363-369.
61. Negrea, A., Bjur, E., and Ygberg, S. E. (2007). Salicylidene acylhydrazides that affect type III protein secretion in Salmonella enterica serovar typhimurium. Antimicrob. Agents Chemother. 51, 2867-2876.
62. Nelson, M. L., Dinardo, A., Hochberg, J., and Armelagos, G. J. (2010). Brief communication: mass spectroscopic characterization of tetracycline in the skeletal remains of an ancient population from Sudanese Nubia 350-550 CE. Am. J. Phys. Anthropol. 143, 151-154.
63. Njoroge, J., and Sperandio, V. (2009). Jamming bacterial communication: new approaches for the treatment of infectious diseases. EMBO Mol. Med. 1, 201-210.
64. Payne, D. J., Gwynn, M. N., Holmes, D. J., and Pompliano, D. L. (2007). Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6, 29-40.
65. Poirel, L., Rodriguez-Martinez, J. M., Mammeri, H., Liard, A., and Nordmann, P. (2005). Origin of plasmid-mediated quinolone resistance determinant QnrA. Antimicrob. Agents Chemother. 49, 3523-3525.
66. Rahman, H., Austin, B., Mitchell, W. J., Morris, P. C., Jamieson, D. J., Adams, D. R., Spragg, A. M., and Schweizer, M. (2010). Novel anti-infective compounds from marine bacteria. Mar. Drugs 8, 498-518.
67. Rasko, D. A., Moreira, C. G., Li de, R., Reading, N. C., Ritchie, J. M., Waldor, M. K., Williams, N., Taussig, R., Wei, S.,Roth, M., Hughes, D. T., Huntley, J. F., Fina, M. W., Falck, J. R., and Sperandio, V. (2008). Targeting QseC signaling and virulence for antibiotic development. Science 321, 1078-1080.
68. Robertson, G. T., Bonventre, E. J., and Doyle, T. B. (2008). In vitro evaluation of CBR-2092, a novel rifamycinquinolone hybrid antibiotic: studies of the mode of action in Staphylococcus aureus. Antimicrob. Agents Chemother. 52, 2313-2323.
69. Rollo, I. M., Williamson, J., and Plackett, R. L. (1952). Acquired resistance to penicillin and to neoarsphenamine in Spirochaeta recurrentis. Br. J. Pharmacol. Chemother. 7, 33-41.
70. Schimmel, P., Tao, J., and Hill, J. (1998). Aminoacyl tRNA synthetases as targets for new anti-infectives. FASEB J. 12, 1599-1609.
71. Sobell, H. M. (1985). Actinomycin and DNA transcription. Proc. Natl. Acad. Sci. U.S.A. 82, 5328-5331.
72. Song, J. S., Jeon, J. H., Lee, J. H., Jeong, S. H., Jeong, B. C., Kim, S. J., Lee, J. H., and Lee, S. H. (2005). Molecular characterization of TEM-type betalactamases identified in cold-seep sediments of Edison Seamount (south of Lihir Island, Papua New Guinea). J. Microbiol. 43, 172-178.
73. Su, Z., and Honek, J. F. (2007). Emerging bacterial enzyme targets. Curr. Opin. Investig. Drugs 8, 140-149.
74. Tarkkanen, A. M., Heinonen, T., and Jogi, R. (2009). P1A recombinant β-lactamase prevents emergence of antimicrobial resistance in gut microflora of healthy subjects during intravenous administration of ampicillin.Antimicrob. Agents Chemother. 53, 2455-2462.
75. Walsh, C. T. (2003). Antibiotics: Actions, Origins, and Resistance. Washington, DC: ASM Press.
76. Wong, R. W., Hägg, U., Samaranayake, L., Yuen, M. K., Seneviratne, C. J., and Kao, R. (2010). Antimicrobial activity of Chinese medicine herbs against common bacteria in oral biofilm. A pilot study. Int. J. Oral Maxillofac. Surg. 39, 599-605.
77. Wright, G. D. (2010). Antibiotic resistance in the environment: a link to the clinic? Curr. Opin. Microbiol.13, 589-594.